|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/62 | |
| A61K 48/00 | |||
| C12N 5/0783 | |||
| C12N 5/10 |
| (11) | Number of the document | 3234144 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15820739.9 |
| Date of filing the European patent application | 2015-12-14 | |
| (97) | Date of publication of the European application | 2017-10-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/065629 |
| Date | 2015-12-14 |
| (87) | Number | WO 2016/100236 |
| Date | 2016-06-23 |
| (30) | Number | Date | Country code |
| 201462092149 P | 2014-12-15 | US |
| (72) |
SPENCER, David, M., US
FOSTER, Aaron, Edward, US
BAYLE, Joseph, Henri, US
SLAWIN, Kevin, M., US
COLLINSON-PAUTZ, Matthew, R., US
|
| (73) |
Bellicum Pharmaceuticals, Inc.,
2130 West Holcombe Boulevard Ste. 850, Houston, TX 77030,
US
|
| (54) | METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS |
| METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS |